Question 1

What is the share price of Concord Biotech Ltd today?

Accepted Answer

Concord Biotech Ltd (CONCORDBIO) is trading at ₹1,229.3. The price shown is the latest available from the exchange feed and updates through the trading session.

Question 2

What is CONCORDBIO’s P/E ratio versus the sector?

Accepted Answer

CONCORDBIO trades at a P/E of 49.8. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.

Question 3

What is CONCORDBIO’s dividend yield?

Accepted Answer

CONCORDBIO has a dividend yield of 0.56%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.

Question 4

What is CONCORDBIO’s 52-week high and low?

Accepted Answer

CONCORDBIO has traded between ₹987 and ₹1,615 over the past year. The Trading Data block shows where the current price sits inside that band.

Question 5

What is the market capitalisation of Concord Biotech Ltd?

Accepted Answer

Concord Biotech Ltd has a market capitalisation of ₹14,169 crore.

Question 6

What is CONCORDBIO’s return on equity?

Accepted Answer

CONCORDBIO reports a return on equity of 12.6%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Biotechnology.

Question 7

Who are CONCORDBIO’s competitors?

Accepted Answer

The Peers block on this page lists other Biotechnology companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.

Question 8

What is CONCORDBIO’s promoter holding?

Accepted Answer

Promoters hold 44.08% of CONCORDBIO. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.

Question 9

Which indices include CONCORDBIO?

Accepted Answer

Index membership is listed in the Context block on this page, along with the weight CONCORDBIO carries in each. That weight is what determines how much passive money tracks the stock.

Question 10

Is Concord Biotech Ltd a good buy?

Accepted Answer

We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from CONCORDBIO’s own numbers. The judgement is yours.

Revenue	₹1,055 crore
Net profit	₹263 crore
Operating margin	36%
EPS	₹25.17

CONCORDBIO

CONCORDBIO

Fundamental Strength Index

Profitability

Growth

Segment Results

Working Capital & Efficiency

CONCORDBIO financial summary